{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:41:09Z","timestamp":1707525669517},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,17]]},"DOI":"10.7759\/cureus.52427","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T11:59:31Z","timestamp":1705492771000},"source":"Crossref","is-referenced-by-count":0,"title":["Relationship Between Pulmonary Artery Pressure and Inflammation Parameters"],"prefix":"10.7759","author":[{"given":"Sabri","family":"Abu\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper MM","year":"2013","unstructured":"Hoeper MM, Bogaard HJ, Condliffe R, et al.. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013, 62:D42-50. 10.1016\/j.jacc.2013.10.032","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7326\/AITC202104200","article-title":"Pulmonary hypertension","volume":"174","author":"Poch D","year":"2021","unstructured":"Poch D, Mandel J. Pulmonary hypertension. Ann Intern Med. 2021, 174:ITC49-64. 10.7326\/AITC202104200","journal-title":"Ann Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050850","article-title":"Health-related quality of life and mortality in heart failure: the Global Congestive Heart Failure study of 23 000 patients from 40 countries","volume":"143","author":"Johansson I","year":"2021","unstructured":"Johansson I, Joseph P, Balasubramanian K, et al.. Health-related quality of life and mortality in heart failure: the Global Congestive Heart Failure study of 23 000 patients from 40 countries. Circulation. 2021, 143:2129-42. 10.1161\/CIRCULATIONAHA.120.050850","journal-title":"Circulation"},{"key":"ref4","article-title":"Pulmonary hypertension and chronic cor pulmonale in COPD","volume":"2","author":"Shujaat A","year":"2007","unstructured":"Shujaat A, Minkin R, Eden E. Pulmonary hypertension and chronic cor pulmonale in COPD. Int J Chron Obstruct Pulmon Dis. 2007, 2:273-82.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.01.051","article-title":"Pulmonary hypertension in heart failure: pathophysiology, pathobiology, and emerging\u00a0clinical\u00a0perspectives","volume":"69","author":"Guazzi M","year":"2017","unstructured":"Guazzi M, Naeije R. Pulmonary hypertension in heart failure: pathophysiology, pathobiology, and emerging\u00a0clinical\u00a0perspectives. J Am Coll Cardiol. 2017, 69:1718-34. 10.1016\/j.jacc.2017.01.051","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-2143(98)90020-8","article-title":"Pulmonary hypertension and inflammation","volume":"132","author":"Tuder RM","year":"1998","unstructured":"Tuder RM, Voelkel NF. Pulmonary hypertension and inflammation. J Lab Clin Med. 1998, 132:16-24. 10.1016\/s0022-2143(98)90020-8","journal-title":"J Lab Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2019.05.002","article-title":"Inflammation in pulmonary artery hypertension","volume":"118-9","author":"Sakuma M","year":"2019","unstructured":"Sakuma M, Toyoda S, Inoue T, Node K. Inflammation in pulmonary artery hypertension. Vascul Pharmacol. 2019, 118-9:106562. 10.1016\/j.vph.2019.05.002","journal-title":"Vascul Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-15-47","article-title":"Inflammatory cytokines in pulmonary hypertension","volume":"15","author":"Groth A","year":"2014","unstructured":"Groth A, Vrugt B, Brock M, Speich R, Ulrich S, Huber LC. Inflammatory cytokines in pulmonary hypertension. Respir Res. 2014, 15:47. 10.1186\/1465-9921-15-47","journal-title":"Respir Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02403-2017","article-title":"How does inflammation contribute to pulmonary hypertension?","volume":"51","author":"Kumar R","year":"2018","unstructured":"Kumar R, Graham B. How does inflammation contribute to pulmonary hypertension?. Eur Respir J. 2018, 51:1702403. 10.1183\/13993003.02403-2017","journal-title":"Eur Respir J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/14017431.2020.1846774","article-title":"A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index","volume":"55","author":"Gok M","year":"2021","unstructured":"Gok M, Kurtul A. A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index. Scand Cardiovasc J. 2021, 55:91-6. 10.1080\/14017431.2020.1846774","journal-title":"Scand Cardiovasc J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2028","article-title":"Pulmonary hypertension: diagnosis and management","volume":"346","author":"Kiely DG","year":"2013","unstructured":"Kiely DG, Elliot CA, Sabroe I, Condliffe R. Pulmonary hypertension: diagnosis and management. BMJ. 2013, 346:f2028. 10.1136\/bmj.f2028","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-5890(01)00042-6","article-title":"Human C-reactive protein: expression, structure, and function","volume":"38","author":"Volanakis JE","year":"2001","unstructured":"Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol. 2001, 38:189-97. 10.1016\/s0161-5890(01)00042-6","journal-title":"Mol Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v15.i1.13","article-title":"Role of fibrinogen, albumin and fibrinogen to albumin ratio in determining angiographic severity and outcomes in acute coronary syndrome","volume":"15","author":"Makkar K","year":"2023","unstructured":"Makkar K, Sharma YP, Batta A, Hatwal J, Panda PK. Role of fibrinogen, albumin and fibrinogen to albumin ratio in determining angiographic severity and outcomes in acute coronary syndrome. World J Cardiol. 2023, 15:13-22. 10.4330\/wjc.v15.i1.13","journal-title":"World J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S443282","article-title":"Prognostic value of fibrinogen-to-albumin ratio in coronary three-vessel disease","volume":"16","author":"Li X","year":"2023","unstructured":"Li X, Wang Z, Zhu Y, et al.. Prognostic value of fibrinogen-to-albumin ratio in coronary three-vessel disease. J Inflamm Res. 2023, 16:5767-77. 10.2147\/JIR.S443282","journal-title":"J Inflamm Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210383","article-title":"Albumin is a component of the esterase status of human blood plasma","volume":"24","author":"Belinskaia DA","year":"2023","unstructured":"Belinskaia DA, Voronina PA, Popova PI, et al.. Albumin is a component of the esterase status of human blood plasma. Int J Mol Sci. 2023, 24:10383. 10.3390\/ijms241210383","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7100333","article-title":"The c-reactive protein\/albumin ratio as a predictor of mortality in critically ill patients","volume":"7","author":"Park JE","year":"2018","unstructured":"Park JE, Chung KS, Song JH, et al.. The c-reactive protein\/albumin ratio as a predictor of mortality in critically ill patients. J Clin Med. 2018, 7:333. 10.3390\/jcm7100333","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0003319717743325","article-title":"Assessment of relationship between C-reactive protein to albumin ratio and coronary artery disease severity in patients with acute coronary syndrome","volume":"70","author":"\u00c7a\u011fda\u015f M","year":"2019","unstructured":"\u00c7a\u011fda\u015f M, Renc\u00fczo\u011fullari I, Karakoyun S, et al.. Assessment of relationship between C-reactive protein to albumin ratio and coronary artery disease severity in patients with acute coronary syndrome. Angiology. 2019, 70:361-8. 10.1177\/0003319717743325","journal-title":"Angiology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/14017431.2019.1590628","article-title":"Prognostic efficacy of C-reactive protein\/albumin ratio in ST elevation myocardial infarction","volume":"53","author":"\u00c7\u0131nar T","year":"2019","unstructured":"\u00c7\u0131nar T, \u00c7a\u011fda\u015f M, Renc\u00fczo\u011fullar\u0131 \u0130, et al.. Prognostic efficacy of C-reactive protein\/albumin ratio in ST elevation myocardial infarction. Scand Cardiovasc J. 2019, 53:83-90. 10.1080\/14017431.2019.1590628","journal-title":"Scand Cardiovasc J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22457","article-title":"Relationship between C-reactive protein\/albumin ratio and coronary artery disease severity in patients with stable angina pectoris","volume":"32","author":"Karaba\u011f Y","year":"2018","unstructured":"Karaba\u011f Y, \u00c7a\u011fda\u015f M, Rencuzogullari I, et al.. Relationship between C-reactive protein\/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. J Clin Lab Anal. 2018, 32:e22457. 10.1002\/jcla.22457","journal-title":"J Clin Lab Anal"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4065\/84.2.191","article-title":"Pulmonary hypertension: diagnosis and management","volume":"84","author":"McGoon MD","year":"2009","unstructured":"McGoon MD, Kane GC. Pulmonary hypertension: diagnosis and management. Mayo Clin Proc. 2009, 84:191-207. 10.4065\/84.2.191","journal-title":"Mayo Clin Proc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2021.11.004","article-title":"New prognostic markers in pulmonary arterial hypertension: CRP to albumin ratio and uric acid","volume":"100","author":"Cerik IB","year":"2022","unstructured":"Cerik IB, Dindas F, Koyun E, Dereli S, Sahin A, Turgut OO, Gul I. New prognostic markers in pulmonary arterial hypertension: CRP to albumin ratio and uric acid. Clin Biochem. 2022, 100:22-8. 10.1016\/j.clinbiochem.2021.11.004","journal-title":"Clin Biochem"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.12.038","article-title":"C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension","volume":"53","author":"Quarck R","year":"2009","unstructured":"Quarck R, Nawrot T, Meyns B, Delcroix M. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol. 2009, 53:1211-8. 10.1016\/j.jacc.2008.12.038","journal-title":"J Am Coll Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/0300060515589394","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in pulmonary arterial hypertension","volume":"43","author":"\u00d6zpelit E","year":"2015","unstructured":"\u00d6zpelit E, Akdeniz B, \u00d6zpelit ME, et al.. Prognostic value of neutrophil-to-lymphocyte ratio in pulmonary arterial hypertension. J Int Med Res. 2015, 43:661-71. 10.1177\/0300060515589394","journal-title":"J Int Med Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/222725-relationship-between-pulmonary-artery-pressure-and-inflammation-parameters","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:58Z","timestamp":1707509578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/222725-relationship-between-pulmonary-artery-pressure-and-inflammation-parameters"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.52427","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,17]]}}}